The current study by Kaoutzanis et al contributes significantly to the literature because it includes over 129,000 patients undergoing 24 different aesthetic surgery procedures across the United States from 2008 to 2013. 3 The large sample of contemporary patients, the ability to evaluate infection risk for individual procedures, procedure categories, and multiple simultaneous procedures, and the exploration of risk factors such as smoking, diabetes, and obesity distinguish this study from prior efforts.
The authors used the CosmetAssure™ database to identify patient variables for 24 covered aesthetic procedures performed by enrolled surgeons. Surgeons must be either board-certified or board-eligible in plastic surgery to participate in the CosmetAssure™ private insurance program, which is now available in all 50 states (after an expansion that took place during the study period). Using information submitted by these providers, the authors assessed risk factors for the occurrence of major SSI, defined as necessitating emergency room visit, hospital admission, or reoperation within 30 days of the initial surgery. Overall, they found a low risk of major SSI (0.46%), which was lower than both the majority of previously reported rates in aesthetic surgery, 2, 3 and the overall SSI rates that are publicly reported for non-aesthetic procedures (including hysterectomies [1.0%], hip arthroplasty [0.67%-2.4%], and knee arthroplasty [0.58%-1.6%]). 4 In multivariate analysis, increasing age, smoking, procedures performed on the trunk/extremities compared to the face or breast, multiple simultaneous procedures, female sex, increasing BMI, procedures performed outside the office, and diabetes mellitus (DM) were all associated with an elevated risk of SSI.
In general, the risk for SSI varies depending on both patient and procedure-related risk factors. 2 Prior studies have shown that DM is a strong risk factor for SSIs in more invasive procedures, such as cardiothoracic surgery, colorectal surgery, and other general surgical procedures. 5, 6 Obesity has also been linked to increased SSI risk in numerous types of procedures, including spinal, abdominal, and cardiac surgeries. [7] [8] [9] [10] Prior data regarding these risk factors in aesthetic surgery, however, have recently been described as limited and conflicting. 11, 12 For example, a review of 313 patients who had a complex abdominal wall reconstruction performed identified increased rates of reoperation and skin necrosis in obese patients compared to those with lower BMIs, but did not find clear differences in infection risk. The highest SSI rate of 22.5% was seen in the group with BMI ≥ 35, but this was not statistically significant. 13 This study, however, has the advantage of a much larger cohort and the ability to examine data from multiple types of procedures. The relationships observed between both DM and obesity and the risk of SSI argue that these factors should be considered in pre-procedure risk stratification for aesthetic surgery.
The observed infection rate of 0.46% provides reassurance to both referring providers and patients undergoing cosmetic surgical procedures. This low rate, as the authors acknowledge, reflect optimal conditions, with procedures performed by board-certified or board-eligible plastic surgeons invested in reporting their data. Regardless, the low risks of SSI seen here should be considered in patients' decision-making about who should perform their surgery and where it should be performed. Recent studies have highlighted the dangers of "cosmetic tourism," with reports of patients developing challenging surgical site infections with atypical mycobacterial organisms after traveling to have surgery in a developing country.
14,15 While uncommon, the risks for severe SSI and adverse cosmetic outcomes from cosmetic tourism likely offset the potential cost savings, when compared to the low risk seen here with a credentialed provider. Dissemination of these results to primary care providers, who are often the initial point of contact for patients considering plastic surgery and medical tourism, may help them to provide patients with critical, relevant information.
The incidence of SSIs was significantly lower for officebased surgeries than for those performed in accredited surgery centers or hospitals, which was surprising. As the authors note, this may reflect accurate patient risk assessment by surgeons, with procedures for more complex patients performed in the higher-acuity facilities. A stratification of surgical procedures by location and medical comorbidities would help to clarify this. If the distribution of procedure types and patients were found to be similar across all facilities, then investigation of infection control practices and OR decontamination policies in the different types of surgical facilities would be an important future direction.
One risk factor not addressed in this study, as acknowledged by the authors, is the use of perioperative antibiotic prophylaxis. The clinical practice guidelines for surgical prophylaxis, issued jointly by several professional societies, recommend prophylaxis for contaminated procedures and clean procedures with risk factors. 16 The 2014 consensus statement of the American Association of Plastic Surgeons, based on 67 studies, recommended antibiotic administration for contaminated aesthetic procedures involving the head, neck, skin, or hands, and for breast surgeries, although they rated the evidence quality "low" or "very low" and graded every recommendation as "weak."
17 Additional research is needed to identify the microbiology of SSI, evaluate the efficacy of perioperative antibiotic prophylaxis in aesthetic surgical procedures, but this is not currently captured in the CosmetAssure™ database. While awaiting additional data, this study may help to guide aesthetic surgery practitioners in making decisions about prophylactic antibiotic use. Given the increased SSI rates in older patients with medical comorbidities and the increasing realization that antibiotics cause significant disruption of the gut microbiome, 18 it may be most effective to target perioperative antibiotic administration to patients undergoing contaminated procedures and to those with at least one SSI risk factor undergoing clean procedures.
SSIs that did not meet criteria for ED visit, hospital admission, or reoperation also warrant further study, since even relatively minor SSIs can affect wound healing, postoperative cosmetic appearance and antibiotic use. The Infectious Disease Society of America (IDSA) guidelines do not recommend antibiotic administration for all SSIs in the outpatient setting, as some can be successfully managed with close observation, frequent dressing changes, and/or debridement if patients do not have surrounding cellulitis or systemic symptoms. 19 Unnecessary antibiotic prescriptions have potential consequences for individual patients beyond disruption of the gut microbiome, including medication side effects, drug-drug interactions, and increased rates of Clostridium difficile infection, in addition to the public health consequences of increasing antibiotic resistance and healthcare costs. 20 The ability to characterize both the incidence of more minor surgical site complications and the extent to which outpatient antibiotics are prescribed could help to target future surgical guidelines and antibiotic stewardship interventions.
This important study found a low incidence of SSI, and offers both reassurance regarding the overall safety of aesthetic surgical procedures, and potential targets for intervention with respect to risk stratification and guideline development. The risk factors for SSI identified in this study, including cigarette smoking, diabetes, obesity, and increasing age, can be incorporated into preoperative discussions with patients and decision making about the need for perioperative antibiotic prophylaxis. This study also highlights the need to further explore the efficacy of prophylaxis in aesthetic surgery, along with the microbiology of SSIs, and the impact of minor SSIs. Expanding data collection to include perioperative antibiotic administration and any prescription of outpatient antibiotics in the 30-day post-procedure period could aid in developing further studies.
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